Marco Proietti MD PhD
LightNews LightNews
mproiettimd.bsky.social
Marco Proietti MD PhD
@mproiettimd.bsky.social
120 followers 220 following 1 posts
Associate Professor of Internal and Geriatric Medicine Clinician, Scientist, Music & Arts Lover
Posts Replies Media Videos
Reposted by Marco Proietti MD PhD
liverpoolccs.bsky.social
Hello from LCCS at University of Liverpool, Liverpool John Moores University, Liverpool Heart & Chest Hospital and Liverpool Health Partners. We're expanding our reach here on Bluesky.
👇
Our mission: Tackling cardiac disease and helping people live longer, healthier lives
#teamLCCS #collaboration
November 24, 2024 at 8:02 PM
Reposted by Marco Proietti MD PhD
liverpoolccs.bsky.social
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation
#multimorbidity #Afib bmcmedicine.biomedcentral.com/articles/10....
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries - BMC Medicine
Background In patients with atrial fibrillation (AF), the impact of peripheral artery disease (PAD) on oral anticoagulant (OAC) therapy use and the risk of outcomes remains unclear. Objective To analy...
bmcmedicine.biomedcentral.com
December 2, 2024 at 10:27 AM
Reposted by Marco Proietti MD PhD
giuliofromiti.bsky.social
ESC Heart & Stroke 2024 has just ended - two days of great talks and discussion on heart-brain interactions.

📌 Get ready for the 2025 edition - coming to Italy! 🇮🇹

Save the date:
🗓️ 15-16 November 2025, Milan 🇮🇹

More info:
esc365.escardio.org/event/1888
November 30, 2024 at 2:01 PM
Reposted by Marco Proietti MD PhD
thjournal.bsky.social
💊 Direct Oral Anticoagulants: a quick primer on when to use ✅ and when to avoid ❌

Read on TH 👉 www.thieme-connect.com/products/ejo...

#HemSky #CardioSky
November 30, 2024 at 2:09 PM
Reposted by Marco Proietti MD PhD
hancardiomd.bsky.social
#ArtificialIntelligence and digital tools for design and execution of CV clinical trials

The landscape of #AI in clinical trial planning

academic.oup.com/eurheartj/ad... #CardioEd #CardioSky @drmarthagulati.bsky.social @joyywu.bsky.social @arghavansallesmd.bsky.social @cardioobdoc.bsky.social
November 29, 2024 at 9:34 PM
Reposted by Marco Proietti MD PhD
drjasonandrade.bsky.social
Congrats to Rajeev Pathak, @prashsanders.bsky.social and team on the ARREST-AF RCT.

Incredibly informative data - adjective comprehensive risk factor optimisation significantly improved post ablation AF freedom.

We now have RCT evidence supporting RFM as a foundation and pillar of AF management.
November 18, 2024 at 8:09 PM
Reposted by Marco Proietti MD PhD
thjournal.bsky.social
🌟 We’re on Bluesky! 🌟
Follow us for latest #thrombosis, #haemostasis, and #VascularBiology research !

#MedSky #HemeSky #Thrombosis #Hemostasis #Hematology
#TH
November 27, 2024 at 12:10 PM
Reposted by Marco Proietti MD PhD
giuliofromiti.bsky.social
Hello Bluesky from Athens 🇬🇷 where
ESC Heart and Stroke 2024 is taking place!

The 7th Annual Conference of the ESC
Council on Stroke ⤵️

esc365.escardio.org/event/1665

#Medsky #Cardiosky #Strokesky
November 28, 2024 at 8:26 AM